Rare diseases
Investigational molecules
Locations
Santariskiu G. 1, Vilniaus M. Sav., 08660 Vilnius, Lithuania
Viesosios istaigos Vilniaus universiteto ligonines Santaros kliniku filialas Nacionalinis vezio centras in Vilnius, Lithuania specialises in clinical trials of conditions such as Non-small cell lung cancer, Gastric cancer, Adenocarcinoma gastric, Endometrial cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, focusing on innovative treatments for advanced/metastatic non-small cell lung cancer (NSCLC). By integrating cutting-edge therapies with standard care, the center aims to enhance patient outcomes and quality of life.
Through its pioneering research, the center contributes significantly to the development of new therapeutic approaches, offering hope to patients with challenging cancer diagnoses.
Specializing in immunotherapy, the center explores the potential of immune system modulation to combat cancer. By combining novel agents with established treatments, researchers aim to unlock new pathways for cancer management.
The center's work in this field is instrumental in advancing our understanding of how the immune system can be harnessed to fight cancer, paving the way for more personalized and effective treatment options.
In the realm of pharmacology, the center is dedicated to the study of drug interactions and efficacy in cancer treatment. By evaluating the synergistic effects of combining new drugs with existing therapies, the center seeks to optimize treatment protocols.
Through rigorous research and clinical trials, the center plays a crucial role in refining cancer treatment regimens, ultimately aiming to improve patient survival rates and quality of life.
Clinical trials currently enrolling participants at this site.
Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
LithuaniaRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
LithuaniaA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
LithuaniaA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
LithuaniaStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
LithuaniaStudy of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer
LithuaniaDurvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation
LithuaniaStudy on Teverelix for Patients with Advanced Prostate Cancer
LithuaniaStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
LithuaniaStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
LithuaniaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
LithuaniaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
LithuaniaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
